A result needs to remain linked to the tissue or blood sample it came from. Dividing or extracting a specimen creates new material with its own history.
NCI guidance describes unique identification of specimens and their derivative samples, with recorded origins and links between parent material, aliquots and extractions. That history helps establish which specimen, preparation and handling conditions produced a measurement. Results from different pieces or time points should not silently be treated as measurements of the same input. Tracking supports interpretation and quality management; it does not make a small sample representative of an entire tumor.
Shares Tissue preparation and assay suitability, Pre-analytics: blood-collection tubes and tissue fixation, Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Pre-analytics: blood-collection tubes and tissue fixation, Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Tumour purity, Immune measurements and product evidence.
Shares Finite tissue and specimen allocation, Immune measurements and product evidence.
Shares Tumour purity, Biopsy.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/